Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of GSK2189242A in Native American Infants
NCT01545375Phase 2Completed
- Sponsor
- GSK
- Start
- May 2012
- Primary completion
- Jul 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of GSK 2189242A in otitis media, lower respiratory tract infection (LRTI), sponsored by GSK. Started May 2012; status: completed.
02
Drugs
GSK 2189242A
03
Conditions
otitis medialower respiratory tract infection (LRTI)
Beyond the preview
Go deeper on NCT01545375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01545375.